Revolution Medicines, Inc.
RVMD
$36.63
-$0.64-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.10B | 2.29B | 1.55B | 1.59B | 1.70B |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 31.91M | 38.33M | 29.66M | 34.02M | 25.66M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.13B | 2.33B | 1.58B | 1.62B | 1.73B |
|
|
|||||
| Total Current Assets | 2.13B | 2.33B | 1.58B | 1.62B | 1.73B |
| Net Property, Plant & Equipment | 142.93M | 141.82M | 99.15M | 100.59M | 99.89M |
| Long-term Investments | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Goodwill | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Total Other Intangibles | 56.40M | 56.67M | 56.94M | 57.21M | 57.47M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.83M | 17.57M | 13.16M | 11.31M | 7.19M |
| Total Assets | 2.37B | 2.56B | 1.76B | 1.81B | 1.91B |
|
|
|||||
| Total Accounts Payable | 47.51M | 54.43M | 24.46M | 29.32M | 32.38M |
| Total Accrued Expenses | 97.46M | 96.03M | 76.73M | 67.02M | 52.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.98M | 12.87M | 8.40M | 8.33M | 8.17M |
| Total Finance Division Other Current Liabilities | 651.00K | 583.00K | 1.28M | 657.00K | 744.00K |
| Total Other Current Liabilities | 651.00K | 583.00K | 1.28M | 657.00K | 744.00K |
| Total Current Liabilities | 158.60M | 163.91M | 110.86M | 105.33M | 93.72M |
|
|
|||||
| Total Current Liabilities | 158.60M | 163.91M | 110.86M | 105.33M | 93.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 121.36M | 122.97M | 78.31M | 79.08M | 79.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.24M | 6.21M | 7.52M | 5.18M | 9.31M |
| Total Liabilities | 287.20M | 293.10M | 196.70M | 189.59M | 182.90M |
|
|
|||||
| Common Stock & APIC | 4.03B | 4.00B | 3.11B | 3.01B | 2.98B |
| Retained Earnings | -1.95B | -1.74B | -1.54B | -1.39B | -1.25B |
| Treasury Stock & Other | 1.71M | 1.32M | 3.81M | -1.86M | -1.20M |
| Total Common Equity | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.08B | 2.27B | 1.57B | 1.62B | 1.73B |
|
|
|||||